Riverside to sell Greenphire to Thoma Bravo
The Riverside Company, a global private investor focused on the smaller end of the middle market, has signed a definitive agreement to sell Greenphire, a specialist in financial lifecycle management software for clinical trials, to Thoma Bravo, a software focused private equity firm. The pending transaction is expected to close